Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Share-based Compensation (2013 - 2026)

Xencor (XNCR) posted quarterly Share-based Compensation of $9.6 million for Q1 2026, down 21.71% year-over-year from $12.2 million in Q1 2025, and down 6.13% quarter-over-quarter from $10.2 million in Q4 2025.

Analysis

Xencor (XNCR) Share-based Compensation (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Share-based Compensation for 14 consecutive years, with $9.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Share-based Compensation fell 21.71% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $40.6 million (down 24.96% YoY), while the FY2025 annual figure was $43.2 million, down 18.87% from the prior year.
  • Share-based Compensation eased to $9.6 million in Q1 2026 per XNCR's latest filing, from $10.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $51.3 million in Q4 2023 and bottomed at -$30.0 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $11.9 million across 5 years, with a median of $12.3 million in 2024.
  • On a YoY basis, Share-based Compensation climbed as much as 1295.68% in 2022 and fell as far as 1082.08% in 2022.
  • Xencor's Share-based Compensation stood at -$30.0 million in 2022, then soared by 270.9% to $51.3 million in 2023, then sank by 75.96% to $12.3 million in 2024, then declined by 17.41% to $10.2 million in 2025, then slipped by 6.13% to $9.6 million in 2026.
  • Business Quant data shows XNCR's Share-based Compensation at $9.6 million in Q1 2026, $10.2 million in Q4 2025, and $10.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Xencor 2.02 Bn 1.65 Bn - 9.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.19 Mn
Mar 31, 2026 9.56 Mn
Dec 31, 2025 10.19 Mn
Sep 30, 2025 10.09 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 12.21 Mn
Dec 31, 2024 12.33 Mn
Sep 30, 2024 12.34 Mn
Jun 30, 2024 17.19 Mn
Mar 31, 2024 11.42 Mn
Dec 31, 2023 14.70 Mn
Sep 30, 2023 12.90 Mn
Jun 30, 2023 13.56 Mn
Mar 31, 2023 12.60 Mn
Dec 31, 2022 12.75 Mn
Sep 30, 2022 14.97 Mn
Jun 30, 2022 15.06 Mn
Mar 31, 2022 15.32 Mn
Dec 31, 2021 10.39 Mn
Sep 30, 2021 13.24 Mn